Court permits MedQuist to buy rival Spheris for $116.3M

Jeff Byers | | Health Imaging | Artificial Intelligence
Medical transcription company MedQuist, its majority shareholder CBay and health IT company Spheris has announced that the U.S. Bankruptcy Court for the District of Delaware has approved the sale of substantially all of Spheris’ assets to MedQuist and CBay.

In February, MedQuist entered into a “stalking horse” purchase agreement with clinical documentation company Spheris for its domestic business, after Spheris, of Franklin, Tenn., had filed for Chapter 11 bankruptcy protection.

The purchase price is $98.8 million in cash and an unsecured subordinated promissory note issued by MedQuist Transcriptions in an aggregate principal amount of $17.5 million, according to MedQuist.

Under the terms of the sale, the Mt. Laurel, N.J.-based MedQuist will acquire Spheris’ U.S. assets and CBay will acquire the stock of Spheris India Private Limited, a subsidiary of Spheris.

The companies expect the transaction to close in April, MedQuist added.

Jeff Byers

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.